Comprehensive Genomic profiling (CGP) is becoming standard of care in oncology. It allows clinicians to maximize clinical information from limited biopsy samples so that patients are matched with approved therapies or enrolled in relevant clinical trials.
In this workshop, our panel will describe the implementation of a CGP assay at their institutions. They will also discuss how flexible automation, sample batching, data analysis and reporting solutions are key to offer CGP testing so that data access and turn-around time can benefit patients.
Sue Beruti, MD, MHA
Sr. Medical Director,
Associate Professor & Director Molecular Pathology
University of Vermont
Larner College of Medicine
Chief Scientific Officer and Director Genomics Technologies
OmniSeq Inc., Roswell Park Comprehensive Cancer Center
Jeremy Wallentine, MD